LG Chem: Hyperuricemia trials

The registry lists 11 Hyperuricemia studies with LG Chem as lead sponsor. 0 are open to participants now and 1 have results posted.

Early Phase 1 1Phase 1 7Phase 2 1Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With HyperuricemiaCompletedNCT03934099Phase 2Results posted
• Effect of Tigulixostat on the Pharmacokinetics of TheophyllineCompletedNCT06189404Phase 1
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout PatientsCompletedNCT05586971Phase 3
• Tigulixostat, Phase 3 Study, Placebo Controlled in Gout PatientsCompletedNCT05586958Phase 3
• Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female SubjectsCompletedNCT04966325Early Phase 1
• Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy AdultsCompletedNCT04886050Phase 1
• The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy AdultsCompletedNCT04139824Phase 1
• Mass Balance Study of [14C]LC350189 in Healthy VolunteersCompletedNCT04070846Phase 1
• Renal PK Study of LC350189CompletedNCT04066712Phase 1
• The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.CompletedNCT03927677Phase 1
• Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189CompletedNCT01361646Phase 1